Phytochemical Name : Rumex vesicarius extract

Properties Information
PhytoCAT-ID PhytoCAT-713
Phytochemical name or plant extracts Rumex vesicarius extract
PMID 32210679
Literature evidence As the phytochemicals and botanical crude extracts have proven their efficacy as natural antiangiogenic agents with minimum toxicities, there is need to explore varieties of medicinal plants for novel antiangiogenic compounds.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Methanol, Chloroform, ethyl acetate and n-hexane extract
Source of phytochemicals or plant Extracts Rumex vesicarius
Geographical availability Afghanistan, Algeria, Assam, Bangladesh, Canary Is., Cape Verde, Chad, Djibouti, Egypt, Eritrea, Gulf States, India, Iran, Iraq, Kuwait, Lebanon-Syria, Libya, Mauritania, Morocco, Myanmar, Niger, Oman, Pakistan, Palestine, Saudi Arabia, Sinai, Somalia, Sudan, Tunisia, West Himalaya, Western Sahara, Yemen
Plant parts Root, Stem, Leaves and Flowers
Other cancers Breast cancer, Colon carcinoma, Hepatocellular carcinoma
Target gene or protein NA
Gene or Protein evidence NA
Target pathways NA
IC50 Chloroform extract of stem - 33.45 ± 0.24 µM against MCF-7 Ethyl acetate extract of stem - 64.26 ± 0.33 µM against MCF-7 The IC50 values of the crude extracts prepared from the roots, and leaves were above than 500 µM.
Potency R. vesicarius can further be tested in clinical trials in order to explore its therapeutic potential as an effective and safe natural anticancer product.
Cell line/ mice model MCF-7, HepG2, Lovo, Caco-2
Additional information  Moreover, the crude extract prepared from other plants parts such as roots, leaves and flowers of R. vesicarius were completely in active in term of antiangiogenic activity in transgenic zebrafish embryos.
PubChem ID NA
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:697616-1
Safety NA